Drugs / Norelgesetromin
last change Dec 2023 re-read 3 minutes ago

Norelgesetromin

Developed for
COVID-19
Investigated by
CMN "20 de Noviembre"

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT04539626 Oct 2020 → Apr 2023 COVID-19 CMN "20 de Noviembre" Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Norelgesetromin “Drug: Norelgesetromin 6mg / Ethinyl estradiol 0.60mg” NCT04539626 ↗